Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Bellati

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Frontiers in Immunology|October 11, 2017
Tumor-Derived Microvesicles Modulate Antigen Cross-Processing <i>via</i> Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic CellsFederico Battisti, Chiara Napoletano, Hassan Rahimi Koshkaki, et al.
International Journal of Cancer|October 24, 2013
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cellsMarino Paroli, Filippo Bellati, Melissa Videtta, et al.
Cancers|March 28, 2025
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot StudyPasquale Sibilio, Ilaria Grazia Zizzari, Alain Gelibter, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 17, 2011
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapyIlaria Grazia Zizzari, Filippo Veglia, Federica Taurino, et al.
Frontiers in Immunology|January 2, 2025
Anti-PD1 therapies induce an early expansion of Ki67<sup>+</sup>CD8<sup>+</sup> T cells in metastatic non-oncogene addicted NSCLC patientsAlain Gelibter, Lucrezia Tuosto, Angela Asquino, et al.
Cancer Treatment Reviews|June 3, 2020
Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trialsIlary Ruscito, Filippo Bellati, Isabelle Ray-Coquard, et al.
Journal of Translational Medicine|April 3, 2024
CD137<sup>+</sup> and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-lineAlain Gelibter, Angela Asquino, Lidia Strigari, et al.
Cancers|April 30, 2021
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized TrialsMaria Luisa Gasparri, Thorsten Kuehn, Ilary Ruscito, et al.
Journal of Contemporary Brachytherapy|March 20, 2020
The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic reviewValentina Lancellotta, Francesca De Felice, Lisa Vicenzi, et al.
Journal of Contemporary Brachytherapy|April 26, 2021
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic reviewFrancesca De Felice, Valentina Lancellotta, Lisa Vicenzi, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Frontiers in Immunology|October 11, 2017
Tumor-Derived Microvesicles Modulate Antigen Cross-Processing <i>via</i> Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic CellsFederico Battisti, Chiara Napoletano, Hassan Rahimi Koshkaki, et al.
International Journal of Cancer|October 24, 2013
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cellsMarino Paroli, Filippo Bellati, Melissa Videtta, et al.
Cancers|March 28, 2025
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot StudyPasquale Sibilio, Ilaria Grazia Zizzari, Alain Gelibter, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 17, 2011
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapyIlaria Grazia Zizzari, Filippo Veglia, Federica Taurino, et al.
Frontiers in Immunology|January 2, 2025
Anti-PD1 therapies induce an early expansion of Ki67<sup>+</sup>CD8<sup>+</sup> T cells in metastatic non-oncogene addicted NSCLC patientsAlain Gelibter, Lucrezia Tuosto, Angela Asquino, et al.
Cancer Treatment Reviews|June 3, 2020
Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trialsIlary Ruscito, Filippo Bellati, Isabelle Ray-Coquard, et al.
Journal of Translational Medicine|April 3, 2024
CD137<sup>+</sup> and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-lineAlain Gelibter, Angela Asquino, Lidia Strigari, et al.
Cancers|April 30, 2021
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized TrialsMaria Luisa Gasparri, Thorsten Kuehn, Ilary Ruscito, et al.
Journal of Contemporary Brachytherapy|March 20, 2020
The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic reviewValentina Lancellotta, Francesca De Felice, Lisa Vicenzi, et al.
Journal of Contemporary Brachytherapy|April 26, 2021
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic reviewFrancesca De Felice, Valentina Lancellotta, Lisa Vicenzi, et al.
Pageof 11